Hong, D., Si, L., Jiang, M., Shao, H., Ming, W., Zhao, Y., . . . Shi, L. (2019). Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review. PharmacoEconomics, 37(6), 777-818. https://doi.org/10.1007/s40273-019-00774-9
Chicago Style (17th ed.) CitationHong, Dongzhe, Lei Si, Minghuan Jiang, Hui Shao, Wai-kit Ming, Yingnan Zhao, Yan Li, and Lizheng Shi. "Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review." PharmacoEconomics 37, no. 6 (2019): 777-818. https://doi.org/10.1007/s40273-019-00774-9.
MLA (9th ed.) CitationHong, Dongzhe, et al. "Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review." PharmacoEconomics, vol. 37, no. 6, 2019, pp. 777-818, https://doi.org/10.1007/s40273-019-00774-9.